Magnesium Deficiency In Patients Hospitalized in Internal Medicine Wards

Status Recruiting

Clinical Trial Summary

Hypomagnesemia is a common entity in the inpatient and outpatient setting. in previous retrospective study hypomagnesemic patients have higher mortality and longer hospitalization. whether hypomagnesemia is merely a marker of poor prognosis, or whether replacing it can improve outcomes is unclear. The current standard of care is to discharge these patients without workup or further treatment, even if patients had received intravenous therapy while hospitalized. The investigator wish to examine prospectively whether giving replacement therapy affects mortality, length of hospital stay and overall well-being. In order to replete intracellular levels and replete magnesium stores, magnesium should be given for several months.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03088852
Study type	Interventional
Source	HaEmek Medical Center, Israel
Contact	Frieda Wolf
Phone	972-4-6495476
Email	friedawo@clalit.org.il
Status	Recruiting
Phase	Phase 4
Start date	May 10, 2017
Completion date	December 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01700998` - Magnesium Replacement Therapy to Prevent Acute Renal Failure in Critically Ill Patients	N/A
Active, not recruiting	`NCT03976440` - Simplified Regional Citrate Anticoagulation Protocols for CVVH, CVVHDF and SLED: a Pilot Study
Completed	`NCT02690012` - Feasibility of Using an Integrated Consent Model to Compare Two Standard of Care Regimens for the Management of Hypomagnesemia From Anti-Cancer Therapies	N/A
Completed	`NCT00603499` - Magnesium and Metabolic Syndrome	Phase 4
Completed	`NCT04426994` - Hypomagnesemia Associated With Proton-Pump Inhibitor Use
Completed	`NCT00994006` - The Absorption of Magnesium Oxide Compared to Citrate in Healthy Subjects	Phase 4
Recruiting	`NCT00282620` - Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life.	Phase 4
Terminated	`NCT03812380` - Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate	Phase 3
Completed	`NCT04351451` - Hypomagnesemia and Hypocalcemia Association Following Thyroidectomy
Recruiting	`NCT04382157` - Magnesium Replacement and Hyperglycemia After Kidney Transplantation	Phase 1/Phase 2
Completed	`NCT02216877` - Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease	Phase 1/Phase 2
Not yet recruiting	`NCT05998863` - EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy	Phase 3
Not yet recruiting	`NCT06353750` - Intracellular Magnesium and Heart Failure